pentobarbital will reduce the level or outcome of buprenorphine, extensive-performing injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Clients who transfer to buprenorphine prolonged-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to